ปรัชญา: ความสำเร็จที่แท้จริงอยู่ที่การนำความรู้ไปประยุกต์ใช้เพื่อประโยชน์สุขแก่มวลมนุษยชาติ

You are here

ผลงานวิจัย

Division of Allergy Immunology & Rheumatology

2021

  1. Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. Wang CW, Tassaneeyakul W, Chen CB, Chen WT, Teng YC, Huang CY, Sukasem C, Lu CW, Lee YS, Choon SE, Nakkam N, Hui RC, Huang YH, Chang YC, Lin YY, Chang CJ, Chiu TM, Chantratita W, Konyoung P, Lee CN, Klaewsongkram J, Rerkpattanapipat T, Amornpinyo W, Saksit N, Rerknimitr P, Huang YH, Lin SH, Hsu CK, Chan CC, Lin YJ, Hung SI, Chung WH; Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium. J Allergy Clin Immunol. 2021 Apr;147(4):1402-1412. doi: 10.1016/j.jaci.2020.08.003. Epub 2020 Aug 10. PMID: 32791162

  2. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy. Sharif H, Acharya S, Dhondalay GKR, Varricchi G, Krasner-Macleod S, Laisuan W, Switzer A, Lenormand M, Kashe E, Parkin RV, Yi Y, Koc M, Fedina O, Vilà-Nadal G, Marone G, Eifan A, Scadding GW, Fear DJ, Nadeau KC, Durham SR, Shamji MH. J Allergy Clin Immunol. 2021 Feb;147(2):663-676. doi: 10.1016/j.jaci.2020.10.035. Epub 2020 Nov 6. PMID: 33160969

  3. Perception of contraceptive counseling and contraceptive use among systemic lupus erythematosus patients. Buasawat P, Manonai J, Ngamjanyaporn P. Contraception. 2021 Jan;103(1):38-43. doi: 10.1016/j.contraception.2020.10.017. Epub 2020 Oct 29. PMID: 33130108

  4. Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01. Pratoomwun J, Thomson P, Jaruthamsophon K, Tiyasirichokchai R, Jinda P, Rerkpattanapipat T, Tassaneeyakul W, Nakkam N, Rerknimitr P, Klaewsongkram J, Srinoulprasert Y, Pirmohamed M, Naisbitt DJ, Sukasem C. Front Immunol. 2021 Apr 29;12:658593. doi: 10.3389/fimmu.2021.658593. eCollection 2021. PMID: 33995375

  5. Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication. Thong BY, Vultaggio A, Rerkpattanapipat T, Schrijvers R. J Allergy Clin Immunol Pract. 2021 Aug;9(8):2958-2966. doi: 10.1016/j.jaip.2021.04.006. PMID: 34366094

  6. HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Satapornpong P, Pratoomwun J, Rerknimitr P, Klaewsongkram J, Nakkam N, Rungrotmongkol T, Konyoung P, Saksit N, Mahakkanukrauh A, Amornpinyo W, Khunarkornsiri U, Tempark T, Wantavornprasert K, Jinda P, Koomdee N, Jantararoungtong T, Rerkpattanapipat T, Wang CW, Naisbitt D, Tassaneeyakul W, Ariyachaipanich M, Roonghiranwat T, Pirmohamed M, Chung WH, Sukasem C. Front Immunol. 2021 May 4;12:661135. doi: 10.3389/fimmu.2021.661135. eCollection 2021. PMID: 34017337

  7. Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis. Sukasem C, Sririttha S, Chaichan C, Nakkrut T, Satapornpong P, Jaruthamsophon K, Jantararoungtong T, Koomdee N, Medhasi S, Oo-Puthinan S, Rerkpattanapipat T, Klaewsongkram J, Rerknimitr P, Tuchinda P, Chularojanamontri L, Tovanabutra N, Suvannang N, Rungrotmongkol T, Saokaew S, Aekplakorn W, Puangpetch A. Pharmacogenomics J. 2021 Jun 26. doi: 10.1038/s41397-021-00247-3. Online ahead of print. PMID: 34175889

  8. The Thai Reference Exome (T-REx) Variant Database. Shotelersuk V, Wichadakul D, Ngamphiw C, Srichomthong C, Phokaew C, Wilantho A, Pakchuen S, Nakhonsri V, Shaw PJ, Wasitthankasem R, Piriyapongsa J, Wangkumhang P, Assawapitaksakul A, Chetruengchai W, Lapphra K, Khuninthong A, Makarawate P, Suphapeetiporn K, Mahasirimongkol S, Satproedprai N, Porntaveetus T, Pisitkun P, Praphanphoj V, Kantaputra P, Tassaneeyakul W, Tongsima S. Clin Genet. 2021 Sep 8. doi: 10.1111/cge.14060. Online ahead of print. PMID: 34496037

  9. Clinical practice guidelines for the diagnosis and management of atopic dermatitis. Kulthanan K, Tuchinda P, Nitiyarom R, Chunharas A, Chantaphakul H, Aunhachoke K, Chularojanamontri L, Rajatanavin N, Jirapongsananuruk O, Vichyanond P, Chatchatee P, Sangsupawanich P, Wananukul S, Singalavanija S, Trakanwittayarak S, Rerkpattanapipat T, Thongngarm T, Wisuthsarewong W, Limpongsanurak W, Kamchaisatian W, Noppakun N. Asian Pac J Allergy Immunol. 2021 Jul 11. doi: 10.12932/AP-010221-1050. Online ahead of print. PMID: 34246205

  10. Application of QuantiFERON ELISA for Detection of Interferon-Gamma Autoantibodies in Adult-Onset Immunodeficiency Syndrome. Khositnithikul R, Laisuan W, Setthaudom C, Sriwanichrak K, Kunakorn M, Srikhirin T, Lumjiaktase P, Vongsakulyanon A. Lab Med. 2021 Aug 31:lmab039. doi: 10.1093/labmed/lmab039. Online ahead of print. PMID: 34463313

  11. Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study. Kittivisuit S, Lerkvaleekul B, Soponkanaporn S, Ngamjanyaporn P, Vilaiyuk S. Pediatr Rheumatol Online J. 2021 Jun 30;19(1):101. doi: 10.1186/s12969-021-00602-5. PMID: 34193176

  12. The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients. Wangriatisak K, Thanadetsuntorn C, Krittayapoositpot T, Leepiyasakulchai C, Suangtamai T, Ngamjanyaporn P, Khowawisetsut L, Khaenam P, Setthaudom C, Pisitkun P, Chootong P. Arthritis Res Ther. 2021 Jul 6;23(1):179. doi: 10.1186/s13075-021-02557-0. PMID: 34229724

  13. Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model. Sakunrangsit N, Metheepakornchai P, Kumpunya S, Greenblatt MB, Leelahavanichkul A, Pisitkun P, Lotinun S. PLoS One. 2021 Apr 16;16(4):e0250215. doi: 10.1371/journal.pone.0250215. eCollection 2021. PMID: 33861790

  14. A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants. Bruminhent J, Autto S, Rotjanapan P, Ngarmjanyaporn P, Bushyakanist A, Kirdlarp S, O-Charoen P, Setthaudom C, Pisitkun P. Open Forum Infect Dis. 2021 May 16;8(6):ofab248. doi: 10.1093/ofid/ofab248. eCollection 2021 Jun. PMID: 34189173

  15. A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology. Prabakaran T, Troldborg A, Kumpunya S, Alee I, Marinković E, Windross SJ, Nandakumar R, Narita R, Zhang BC, Carstensen M, Vejvisithsakul P, Marqvorsen MHS, Iversen MB, Holm CK, Østergaard LJ, Pedersen FS, Pisitkun T, Behrendt R, Pisitkun P, Paludan SR. EBioMedicine. 2021 Apr;66:103314. doi: 10.1016/j.ebiom.2021.103314. Epub 2021 Apr 2. PMID: 33813142

  16. Outcomes of patients with atrial fibrillation with and without diabetes: A propensity score matching of the COOL-AF registry. Krittayaphong R, Aroonsiriwattana S, Ngamjanyaporn P, Patmuk T, Kaewkumdee P; COOL-AF Investigators. Int J Clin Pract. 2021 Jul 29:e14671. doi: 10.1111/ijcp.14671. Online ahead of print. PMID: 34324768

  17. Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury. Saisorn W, Saithong S, Phuengmaung P, Udompornpitak K, Bhunyakarnjanarat T, Visitchanakun P, Chareonsappakit A, Pisitkun P, Chiewchengchol D, Leelahavanichkul A. Front Immunol. 2021 Jun 24;12:669162. doi: 10.3389/fimmu.2021.669162. eCollection 2021. PMID: 34248948

2020

  1. Drug hypersensitivity reactions in Asia: regional issues and challenges. Thong BY, Lucas M, Kang HR, Chang YS, Li PH, Tang MM, Yun J, Fok JS, Kim BK, Nagao M, Rengganis I, Tsai YG, Chung WH, Yamaguchi M, Rerkpattanapipat T, Kamchaisatian W, Leung TF, Yoon HJ, Zhang L, Latiff AHA, Fujisawa T, Thien F, Castells MC, Demoly P, Wang JY, Pawankar R. Asia Pac Allergy. 2020 Jan 30;10(1):e8. doi: 10.5415/apallergy.2020.10.e8. eCollection 2020 Jan. PMID: 32099830 Free PMC article. Review.

  2. Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. Wang CW, Tassaneeyakul W, Chen CB, Chen WT, Teng YC, Huang CY, Sukasem C, Lu CW, Lee YS, Choon SE, Nakkam N, Hui RC, Huang YH, Chang YC, Lin YY, Chang CJ, Chiu TM, Chantratita W, Konyoung P, Lee CN, Klaewsongkram J, Rerkpattanapipat T, Amornpinyo W, Saksit N, Rerknimitr P, Huang YH, Lin SH, Hsu CK, Chan CC, Lin YJ, Hung SI, Chung WH; Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium. J Allergy Clin Immunol. 2021 Apr;147(4):1402-1412. doi: 10.1016/j.jaci.2020.08.003. Epub 2020 Aug 10. PMID: 32791162

  3. Epoetin-alfa induced pruritic maculopapular eruption: Case report and literature review. Rueangsri R, Laisuan W. Asian Pac J Allergy Immunol. 2020 Jun 21. doi: 10.12932/AP-040719-0592. Online ahead of print. PMID: 32563229 Free article.

  4. Efficacy and safety of rituximab biosimilar in refractory lupus. Pongtarakulpanit N, Pisitkun P, Ngamjanyaporn P. Lupus Sci Med. 2020 Nov;7(1):e000442. doi: 10.1136/lupus-2020-000442. PMID: 33139454 Free PMC article.

  5. Endotoxemia and circulating bacteriome in severe COVID-19 patients. Sirivongrangson P, Kulvichit W, Payungporn S, Pisitkun T, Chindamporn A, Peerapornratana S, Pisitkun P, Chitcharoen S, Sawaswong V, Worasilchai N, Kampunya S, Putcharoen O, Thawitsri T, Leelayuwatanakul N, Kongpolprom N, Phoophiboon V, Sriprasart T, Samransamruajkit R, Tungsanga S, Tiankanon K, Lumlertgul N, Leelahavanichkul A, Sriphojanart T, Tantawichien T, Thisyakorn U, Chirathaworn C, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Sitprija V, Kellum JA, Srisawat N. Intensive Care Med Exp. 2020 Dec 7;8(1):72. doi: 10.1186/s40635-020-00362-8. PMID: 33284413 Free PMC article.

  6. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population. Sukasem C, Sririttha S, Tempark T, Klaewsongkram J, Rerkpattanapipat T, Puangpetch A, Boongird A, Chulavatnatol S. Pharmacoepidemiol Drug Saf. 2020 May;29(5):565-574. doi: 10.1002/pds.4979. Epub 2020 Mar 5. PMID: 32134161

  7. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease. Phaopraphat K, Ngamjanyaporn P, Narongroeknawin P, Kasitanon N, Katchamart W. Int J Rheum Dis. 2020 Nov;23(11):1468-1473. doi: 10.1111/1756-185X.13949. Epub 2020 Aug 18. PMID: 32808722

  8. Cutaneous and Extracutaneous Manifestations of Behçet's Disease Linked to Its Disease Activity and Prognosis. Limtong P, Chanprapaph K, Vachiramon V, Ngamjanyaporn P. Clin Cosmet Investig Dermatol. 2020 Aug 25;13:639-647. doi: 10.2147/CCID.S265169. eCollection 2020. PMID: 32904702 Free PMC article.

  9. Meta-analysis of genome-wide association study identifies FBN2 as a novel locus associated with systemic lupus erythematosus in Thai population. Tangtanatakul P, Thumarat C, Satproedprai N, Kunhapan P, Chaiyasung T, Klinchanhom S, Wang YF, Wei W, Wongshinsri J, Chiewchengchol D, Rodsaward P, Ngamjanyaporn P, Suangtamai T, Mahasirimongkol S, Pisitkun P, Hirankarn N. Arthritis Res Ther. 2020 Aug 8;22(1):185. doi: 10.1186/s13075-020-02276-y. PMID: 32771030 Free PMC article.

  10. Diagnostic procedures & practices in drug allergy/hypersensitivity: a survey of 13 Asian countries. Tang MM, Fok JS, Thong BY, Yun J, Li PH, Kang HR, Thien F, Yamaguchi M, Lucas M, Chang YS, Kim BK, Nagao M, Rengganis I, Tsai YG, Chung WH, Rerkpattanapipat T, Kamchaisatian W, Leung TF, Ho JY, Zhang L, Latiff AHA, Fujisawa T, Castells MC, Demoly P, Wang JY, Pawankar R. Asia Pac Allergy. 2020 Oct 15;10(4):e36. doi: 10.5415/apallergy.2020.10.e36. eCollection 2020 Oct. PMID: 33178561 Free PMC article.

  11. Clinical value of in vitro tests for the management of severe drug hypersensitivity reactions. Srinoulprasert Y, Rerkpattanapipat T, Sompornrattanaphan M, Wongsa C, Kanistanon D. Asia Pac Allergy. 2020 Oct 29;10(4):e44. doi: 10.5415/apallergy.2020.10.e44. eCollection 2020 Oct. PMID: 33178569 Free PMC article. Review.

  12. Banana anaphylaxis in Thailand: case series. Thongkhom R, Oncham S, Sompornrattanaphan M, Laisuan W. Asia Pac Allergy. 2020 Jan 26;10(1):e4. doi: 10.5415/apallergy.2020.10.e4. eCollection 2020 Jan. PMID: 32099826 Free PMC article.

  13. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy. Sharif H, Acharya S, Dhondalay GKR, Varricchi G, Krasner-Macleod S, Laisuan W, Switzer A, Lenormand M, Kashe E, Parkin RV, Yi Y, Koc M, Fedina O, Vilà-Nadal G, Marone G, Eifan A, Scadding GW, Fear DJ, Nadeau KC, Durham SR, Shamji MH. J Allergy Clin Immunol. 2021 Feb;147(2):663-676. doi: 10.1016/j.jaci.2020.10.035. Epub 2020 Nov 6. PMID: 33160969

  14. Inhibitory activity of FOXP3+ regulatory T cells reveals high specificity for displaying immune tolerance in remission state rheumatoid arthritis. Kanjana K, Chevaisrakul P, Matangkasombut P, Paisooksantivatana K, Lumjiaktase P. Sci Rep. 2020 Nov 13;10(1):19789. doi: 10.1038/s41598-020-76168-1. PMID: 33188235 Free PMC article.

  15. Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study. Kanjana K, Chevaisrakul P, Matangkasombut P, Paisooksantivatana K, Lumjiaktase P. Front Med (Lausanne). 2020 Feb 4;7:25. doi: 10.3389/fmed.2020.00025. eCollection 2020. PMID: 32118010 Free PMC article.

  16. Genetic Association of Co-Trimoxazole-Induced Severe Cutaneous Adverse Reactions Is Phenotype-Specific: HLA Class I Genotypes and Haplotypes. Sukasem C, Pratoomwun J, Satapornpong P, Klaewsongkram J, Rerkpattanapipat T, Rerknimitr P, Lertpichitkul P, Puangpetch A, Nakkam N, Konyoung P, Khunarkornsiri U, Disphanurat W, Srisuttiyakorn C, Pattanacheewapull O, Kanjanawart S, Kongpan T, Chumworathayi P, Saksit N, Bruminhent J, Tassaneeyakul W, Chantratita W, Pirmohamed M. Clin Pharmacol Ther. 2020 Nov;108(5):1078-1089. doi: 10.1002/cpt.1915. Epub 2020 Jul 21. PMID: 32452529

  17. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry. Wongpraparut N, Siwamogsatham S, Thongsri T, Ngamjanyaporn P, Phrommintikul A, Jirajarus K, Tangcharoen T, Bhumimuang K, Kaewsuwanna P, Krittayaphong R, Pongakasira R, White HD. BMC Cardiovasc Disord. 2020 Jan 9;20(1):8. doi: 10.1186/s12872-019-01311-4. PMID: 31918676 Free PMC article.

  18. Perception of contraceptive counseling and contraceptive use among systemic lupus erythematosus patients. Buasawat P, Manonai J, Ngamjanyaporn P. Contraception. 2021 Jan;103(1):38-43. doi: 10.1016/j.contraception.2020.10.017. Epub 2020 Oct 29. PMID: 33130108

  19. Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect. Issara-Amphorn J, Somboonna N, Pisitkun P, Hirankarn N, Leelahavanichkul A. Lupus. 2020 Sep;29(10):1248-1262. doi: 10.1177/0961203320941106. Epub 2020 Jul 22. PMID: 32700597

  20. Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies. Laisuan W, Pisitkun P, Ngamjanyaporn P, Suangtamai T, Rotjanapan P. Open Forum Infect Dis. 2020 Jan 31;7(2):ofaa035. doi: 10.1093/ofid/ofaa035. eCollection 2020 Feb. PMID: 32099846 Free PMC article.

  21. Deficiency of STING Promotes Collagen-Specific Antibody Production and B Cell Survival in Collagen-Induced Arthritis. Tansakul M, Thim-Uam A, Saethang T, Makjaroen J, Wongprom B, Pisitkun T, Pisitkun P. Front Immunol. 2020 Jun 3;11:1101. doi: 10.3389/fimmu.2020.01101. eCollection 2020. PMID: 32582187 Free PMC article.

  22. Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand. Krittayaphong R, Kunjara-Na-Ayudhya R, Ngamjanyaporn P, Boonyaratavej S, Komoltri C, Yindeengam A, Sritara P, Lip GYH, For The Cool-Af Investigators. J Geriatr Cardiol. 2020 Oct 28;17(10):612-620. doi: 10.11909/j.issn.1671-5411.2020.10.004. PMID: 33224180 Free PMC article.

  23. Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus. Thim-Uam A, Surawut S, Issara-Amphorn J, Jaroonwitchawan T, Hiengrach P, Chatthanathon P, Wilantho A, Somboonna N, Palaga T, Pisitkun P, Leelahavanichkul A. Sci Rep. 2020 Jan 21;10(1):777. doi: 10.1038/s41598-019-57275-0. PMID: 31964918 Free PMC article.

  24. STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation. Thim-Uam A, Prabakaran T, Tansakul M, Makjaroen J, Wongkongkathep P, Chantaravisoot N, Saethang T, Leelahavanichkul A, Benjachat T, Paludan S, Pisitkun T, Pisitkun P. iScience. 2020 Sep 4;23(9):101530. doi: 10.1016/j.isci.2020.101530. eCollection 2020 Sep 25. PMID: 33083760 Free PMC article.

  25. Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series. Surabotsophon M, Klai-On Y, Thanachartwet V, Khunapornphairote S, Chamnanchanunt S, Racharak T, Laisuan W, Sahassananda D, Hapunna S, Jinapuk S, Leelasetakul S, Desakorn V. Clin Case Rep. 2020 Oct 13;8(12):3264-77. doi: 10.1002/ccr3.3407. Online ahead of print. PMID: 33230415 Free PMC article.

  26. Erratum: STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation. Thim-Uam A, Prabakaran T, Tansakul M, Makjaroen J, Wongkongkathep P, Chantaravisoot N, Saethang T, Leelahavanichkul A, Benjachat T, Paludan SR, Pisitkun T, Pisitkun P. iScience. 2020 Nov 1;23(11):101706. doi: 10.1016/j.isci.2020.101706. eCollection 2020 Nov 20.

2019.

  1. Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing. Torres MJ, Adkinson NF Jr, Caubet JC, Khan DA, Kidon MI, Mendelson L, Gomes ER, Rerkpattanapipat T, Zhang S, Macy E; AAAAI/WAO 2018 Symposium Penicillin and Cephalosporin Allergy Testing Working Group. J Allergy Clin Immunol Pract. 2019 Jan;7(1):40-45. doi: 10.1016/j.jaip.2018.07.051. Epub 2018 Sep 20. PMID: 30245291 Review.

  2. Performance of cytokine models in predicting SLE activity. Ruchakorn N, Ngamjanyaporn P, Suangtamai T, Kafaksom T, Polpanumas C, Petpisit V, Pisitkun T, Pisitkun P. Arthritis Res Ther. 2019 Dec 16;21(1):287. doi: 10.1186/s13075-019-2029-1. PMID: 31842967 Free PMC article.

  3. Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment. Saengnipanthkul S, Waikakul S, Rojanasthien S, Totemchokchyakarn K, Srinkapaibulaya A, Cheh Chin T, Mai Hong N, Bruyère O, Cooper C, Reginster JY, Lwin M. Int J Rheum Dis. 2019 Mar;22(3):376-385. doi: 10.1111/1756-185X.13068. Epub 2017 Mar 23. PMID: 28332780 Review.

  4. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study. Yongchairat K, Tanboon J, Waisayarat J, Narongroeknawin P, Chevaisrakul P, Dejthevaporn C, Katchamart W. Clin Rheumatol. 2019 Dec;38(12):3459-3469. doi: 10.1007/s10067-019-04756-2. Epub 2019 Aug 24. PMID: 31446540

  5. Lupus-like Disease in FcγRIIB-/- Mice Induces Osteopenia. Visitchanakun P, Saiworn W, Jongwattanapisan P, Leelahavanichkul A, Pisitkun P, Lotinun S. Sci Rep. 2019 Nov 22;9(1):17342. doi: 10.1038/s41598-019-53963-z. PMID: 31758072 Free PMC article.

  6. Reliability and validity of the Thai Drug Hypersensitivity Quality of Life Questionnaire: a multi-center study. Chongpison Y, Rerknimitr P, Hurst C, Mongkolpathumrat P, Palapinyo S, Chularojanamontri L, Srinoulprasert Y, Rerkpattanapipat T, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Tovanabutra N, Srisuttiyakorn C, Sukasem C, Tuchinda P, Baiardini I, Klaewsongkram J. Int J Qual Health Care. 2019 Aug 1;31(7):527-534. doi: 10.1093/intqhc/mzy207. PMID: 30346532

  7. Efficient short-term expansion of human peripheral blood regulatory T cells for co-culture suppression assay. Kanjana K, Paisooksantivatana K, Matangkasombut P, Chevaisrakul P, Lumjiaktase P. J Immunoassay Immunochem. 2019;40(6):573-589. doi: 10.1080/15321819.2019.1659813. Epub 2019 Aug 28. PMID: 31460830

  8. Nonscarring alopecia in systemic lupus erythematosus: A cross-sectional study with trichoscopic, histopathologic, and immunopathologic analyses. Chanprapaph K, Udompanich S, Visessiri Y, Ngamjanyaporn P, Suchonwanit P. J Am Acad Dermatol. 2019 Dec;81(6):1319-1329. doi: 10.1016/j.jaad.2019.05.053. Epub 2019 May 28. PMID: 31150712 Free article.

  9. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. Chiowchanwisawakit P, Katchamart W, Osiri M, Narongroeknawin P, Chevaisrakul P, Kitumnuaypong T, Siripaitoon B, Louthrenoo W. J Clin Rheumatol. 2019 Jan;25(1):9-15. doi: 10.1097/RHU.0000000000000741. PMID: 29517554

  10. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs. Klaewsongkram J, Sukasem C, Thantiworasit P, Suthumchai N, Rerknimitr P, Tuchinda P, Chularojanamontri L, Srinoulprasert Y, Rerkpattanapipat T, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Tovanabutra N, Srisuttiyakorn C; ThaiSCAR study group. J Allergy Clin Immunol Pract. 2019 Jan;7(1):219-227.e4. doi: 10.1016/j.jaip.2018.05.004. Epub 2018 May 22. PMID: 29800753

  11. Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry. Krittayaphong R, Phrommintikul A, Ngamjanyaporn P, Siriwattana K, Kanjanarutjawiwat W, Chantrarat T, Rojjarekampai R, Kaewcomdee P, Sonkhammee P; COOL-AF Investigators. J Geriatr Cardiol. 2019 Mar;16(3):242-250. doi: 10.11909/j.issn.1671-5411.2019.03.004. PMID: 31080466 Free PMC article.

  12. Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background. Surawut S, Makjaroen J, Thim-Uam A, Wongphoom J, Palaga T, Pisitkun P, Chindamporn A, Leelahavanichkul A. J Microbiol. 2019 Jan;57(1):45-53. doi: 10.1007/s12275-019-8311-8. Epub 2018 Nov 19.

2018

  1. Controversies in Drug Allergy: Beta-Lactam Hypersensitivity Testing. Torres MJ, Adkinson NF Jr, Caubet JC, Khan DA, Kidon MI, Mendelson L, Gomes ER, Rerkpattanapipat T, Zhang S, Macy E; AAAAI/WAO 2018 Symposium Penicillin and Cephalosporin Allergy Testing Working Group. J Allergy Clin Immunol Pract. 2019 Jan;7(1):40-45. doi: 10.1016/j.jaip.2018.07.051. Epub 2018 Sep 20. PMID: 30245291 Review.

  2. Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients. Sukasem C, Chaichan C, Nakkrut T, Satapornpong P, Jaruthamsophon K, Jantararoungtong T, Koomdee N, Sririttha S, Medhasi S, Oo-Puthinan S, Rerkpattanapipat T, Klaewsongkram J, Rerknimitr P, Tuchinda P, Chularojanamontri L, Tovanabutra N, Puangpetch A, Aekplakorn W. J Immunol Res. 2018 Jan 10;2018:2780272. doi: 10.1155/2018/2780272. eCollection 2018. PMID: 29546073 Free PMC article.

  3. Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations. Reynolds JA, McCarthy EM, Haque S, Ngamjanyaporn P, Sergeant JC, Lee E, Lee E, Kilfeather SA, Parker B, Bruce IN. Arthritis Res Ther. 2018 Aug 9;20(1):173. doi: 10.1186/s13075-018-1666-0. PMID: 30092845 Free PMC article.

  4. Cortical Bone Loss in a Spontaneous Murine Model of Systemic Lupus Erythematosus. Saiworn W, Thim-Uam A, Visitchanakun P, Atjanasuppat K, Chantaraaumporn J, Mokdara J, Chungchatupornchai S, Pisitkun P, Leelahavanichkul A, Poolthong S, Baron R, Lotinun S. Calcif Tissue Int. 2018 Dec;103(6):686-697. doi: 10.1007/s00223-018-0464-7. Epub 2018 Aug 16. PMID: 30116830

  5. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial. Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V. Lupus. 2018 Apr;27(4):647-656. doi: 10.1177/0961203317739131. Epub 2017 Nov 6. PMID: 29105558 Clinical Trial.

  6. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus. Thanadetsuntorn C, Ngamjanyaporn P, Setthaudom C, Hodge K, Saengpiya N, Pisitkun P. Sci Rep. 2018 Feb 8;8(1):2620. doi: 10.1038/s41598-018-20947-4. PMID: 29422675 Free PMC article.

  7. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs. Klaewsongkram J, Sukasem C, Thantiworasit P, Suthumchai N, Rerknimitr P, Tuchinda P, Chularojanamontri L, Srinoulprasert Y, Rerkpattanapipat T, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Tovanabutra N, Srisuttiyakorn C; ThaiSCAR study group. J Allergy Clin Immunol Pract. 2019 Jan;7(1):219-227.e4. doi: 10.1016/j.jaip.2018.05.004. Epub 2018 May 22. PMID: 29800753

  8. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Narongroeknawin P, Chevaisrakul P, Kasitanon N, Kitumnuaypong T, Mahakkanukrauh A, Siripaitoon B, Katchamart W; Thai Rheumatism Association. Int J Rheum Dis. 2018 Jan;21(1):170-178. doi: 10.1111/1756-185X.12937. Epub 2016 Nov 5. PMID: 28737837

  9. Skin prick test reactivity to aeroallergens in adult allergy clinic in Thailand: a 12-year retrospective study. Oncham S, Udomsubpayakul U, Laisuan W. Asia Pac Allergy. 2018 Apr 24;8(2):e17. doi: 10.5415/apallergy.2018.8.e17. eCollection 2018 Apr. PMID: 29732293 Free PMC article.

  10. Solenopsis geminata (tropical fire ant) anaphylaxis among Thai patients: its allergens and specific IgE-reactivity. Potiwat R, Tanyaratsrisakul S, Maneewatchararangsri S, Manuyakorn W, Rerkpattanapipat T, Samung Y, Sirivichayakul C, Chaicumpa W, Sitcharungsi R. Asian Pac J Allergy Immunol. 2018 Jun;36(2):101-108. doi: 10.12932/AP-100217-0012. PMID: 28802030 Free article.

  11. The measurement of drug-induced interferon γ-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions. Suthumchai N, Srinoulprasert Y, Thantiworasit P, Rerknimitr P, Tuchinda P, Chularojanamontri L, Rerkpattanapipat T, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Tovanabutra N, Srisuttiyakorn C, Sukasem C, Klaewsongkram J; ThaiSCAR study group. J Eur Acad Dermatol Venereol. 2018 Jun;32(6):992-998. doi: 10.1111/jdv.14890. Epub 2018 Mar 13. PMID: 29478292

  12. The Synergy of Endotoxin and (1→3)-β-D-Glucan, from Gut Translocation, Worsens Sepsis Severity in a Lupus Model of Fc Gamma Receptor IIb-Deficient Mice. Issara-Amphorn J, Surawut S, Worasilchai N, Thim-Uam A, Finkelman M, Chindamporn A, Palaga T, Hirankarn N, Pisitkun P, Leelahavanichkul A. J Innate Immun. 2018;10(3):189-201. doi: 10.1159/000486321. Epub 2018 Jan 31. PMID: 29393221 Free PMC article.

  13. Increased susceptibility against Cryptococcus neoformans of lupus mouse models (pristane-induction and FcGRIIb deficiency) is associated with activated macrophage, regardless of genetic background. Surawut S, Makjaroen J, Thim-Uam A, Wongphoom J, Palaga T, Pisitkun P, Chindamporn A, Leelahavanichkul A. J Microbiol. 2019 Jan;57(1):45-53. doi: 10.1007/s12275-019-8311-8. Epub 2018 Nov 19. PMID: 30456753

  14. Erratum: Correction of Figure 1: The asthma and chronic obstructive pulmonary disease overlap syndrome in tertiary care setting Thailand. Kawamatawong T, Charoenniwassakul S, Rerkpattanapipat T. Asia Pac Allergy. 2018 Feb 21;8(2):e11. doi: 10.5415/apallergy.2018.8.e11. eCollection 2018 Apr.

2017

  1. Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment. Saengnipanthkul S, Waikakul S, Rojanasthien S, Totemchokchyakarn K, Srinkapaibulaya A, Cheh Chin T, Mai Hong N, Bruyère O, Cooper C, Reginster JY, Lwin M. Int J Rheum Dis. 2019 Mar;22(3):376-385. doi: 10.1111/1756-185X.13068. Epub 2017 Mar 23. PMID: 28332780 Review.

  2. The asthma and chronic obstructive pulmonary disease overlap syndrome in tertiary care setting Thailand. Kawamatawong T, Charoenniwassakul S, Rerkpattanapipat T. Asia Pac Allergy. 2017 Oct;7(4):227-233. doi: 10.5415/apallergy.2017.7.4.227. Epub 2017 Oct 26. PMID: 29094021 Free PMC article.

  3. Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions. Yampayon K, Sukasem C, Limwongse C, Chinvarun Y, Tempark T, Rerkpattanapipat T, Kijsanayotin P. Eur J Clin Pharmacol. 2017 Jul;73(7):855-865. doi: 10.1007/s00228-017-2250-2. Epub 2017 Apr 8. PMID: 28391407

  4. Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population. Koomdee N, Pratoomwun J, Jantararoungtong T, Theeramoke V, Tassaneeyakul W, Klaewsongkram J, Rerkpattanapipat T, Santon S, Puangpetch A, Intusoma U, Tempark T, Deesudchit T, Satapornpong P, Visudtibhan A, Sukasem C. Front Pharmacol. 2017 Nov 29;8:879. doi: 10.3389/fphar.2017.00879. eCollection 2017. PMID: 29238301 Free PMC article.

  5. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Katchamart W, Narongroeknawin P, Chevaisrakul P, Dechanuwong P, Mahakkanukrauh A, Kasitanon N, Pakchotanon R, Sumethkul K, Ueareewongsa P, Ukritchon S, Bhurihirun T, Duangkum K, Intapiboon P, Intongkam S, Jangsombatsiri W, Jatuworapruk K, Kositpesat N, Leungroongroj P, Lomarat W, Petcharat C, Sittivutworapant S, Suebmee P, Tantayakom P, Tipsing W, Asavatanabodee P, Chiowchanwisawakit P, Foocharoen C, Koolvisoot A, Louthrenoo W, Siripaitoon B, Totemchokchyakarn K, Kitumnuaypong T; Thai Rheumatism Association. Int J Rheum Dis. 2017 Sep;20(9):1142-1165. doi: 10.1111/1756-185X.12905. Epub 2016 Jul 25. PMID: 27452207 Review.

  6. Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population. Saksit N, Tassaneeyakul W, Nakkam N, Konyoung P, Khunarkornsiri U, Chumworathayi P, Sukasem C, Suttisai S, Piriyachananusorn N, Tiwong P, Chaiyakunapruk N, Sawanyawisuth K, Rerkpattanapipat T, Tassaneeyakul W. Pharmacogenet Genomics. 2017 Jul;27(7):255-263. doi: 10.1097/FPC.0000000000000285. PMID: 28509689

  7. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

  8. Louthrenoo W, Kasitanon N, Katchamart W, Aiewruengsurat D, Chevaisrakul P, Chiowchanwisawakit P, Dechanuwong P, Hanvivadhanakul P, Mahakkanukrauh A, Manavathongchai S, Muangchan C, Narongroeknawin P, Phumethum V, Siripaitoon B, Suesuwan A, Suwannaroj S, Uea-Areewongsa P, Ukritchon S, Asavatanabodee P, Koolvisoot A, Nanagara R, Totemchokchyakarn K, Nuntirooj K, Kitumnuaypong T. Int J Rheum Dis. 2017 Sep;20(9):1166-1184. doi: 10.1111/1756-185X.13130. Epub 2017 Jul 21. PMID: 28730640 Review.

  9. Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population. Tempark T, Satapornpong P, Rerknimitr P, Nakkam N, Saksit N, Wattanakrai P, Jantararoungtong T, Koomdee N, Mahakkanukrauh A, Tassaneeyakul W, Suttisai S, Pratoomwun J, Klaewsongkram J, Rerkpattanapipat T, Sukasem C. Pharmacogenet Genomics. 2017 Dec;27(12):429-437. doi: 10.1097/FPC.0000000000000306. PMID: 28885988

  10. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial. Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V. Lupus. 2018 Apr;27(4):647-656. doi: 10.1177/0961203317739131. Epub 2017 Nov 6. PMID: 29105558 Clinical Trial.

  11. Anaphylaxis following intralesional triamcinolone acetonide (Kenacort) injection. Laisuan W, Wongsa C, Dchapaphapeaktak N, Tongdee M, Chatmapanrangsee J, Rerkpattanapipat T. Asia Pac Allergy. 2017 Apr;7(2):115-118. doi: 10.5415/apallergy.2017.7.2.115. Epub 2017 Apr 6. PMID: 28487843 Free PMC article.

  12. Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey. Ngamjanyaporn P, McCarthy EM, Sergeant JC, Reynolds J, Skeoch S, Parker B, Bruce IN. Lupus Sci Med. 2017 Jun 29;4(1):e000173. doi: 10.1136/lupus-2016-000173. eCollection 2017. PMID: 29238601 Free PMC article.

  13. Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity. Chiriac AM, Rerkpattanapipat T, Bousquet PJ, Molinari N, Demoly P. Allergy. 2017 Apr;72(4):552-561. doi: 10.1111/all.13037. Epub 2016 Nov 23. PMID: 27569064

  14. Successful Subcutaneous Allergen-Specific Immunotherapy in Refractory Atopic Keratoconjunctivitis: A Case Report. Jongkhajornpong P, Laisuan W. Case Rep Ophthalmol. 2017 Dec 14;8(3):562-567. doi: 10.1159/000485174. eCollection 2017 Sep-Dec. PMID: 29422859 Free PMC article.

  15. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. Maverakis E, Wang EA, Shinkai K, Mahasirimongkol S, Margolis DJ, Avigan M, Chung WH, Goldman J, La Grenade L, Pirmohamed M, Shear NH, Tassaeeyakul W, Hoetzenecker W, Klaewsongkram J, Rerkpattanapipat T, Manuyakorn W, Yasuda SU, Sharon VR, Sukhov A, Micheletti R, Struewing J, French LE, Cheng MY. JAMA Dermatol. 2017 Jun 1;153(6):587-592. doi: 10.1001/jamadermatol.2017.0160. PMID: 28296986 Free article. Fc Gamma Receptor IIB Deficient Mice: A Lupus Model with Increased Endotoxin Tolerance-Related Sepsis Susceptibility. Ondee T, Surawut S, Taratummarat S, Hirankarn N, Palaga T, Pisitkun P, Pisitkun T, Leelahavanichkul A. Shock. 2017 Jun;47(6):743-752. doi: 10.1097/SHK.0000000000000796. PMID: 27849678

  16. The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans. Surawut S, Ondee T, Taratummarat S, Palaga T, Pisitkun P, Chindamporn A, Leelahavanichkul A. Sci Rep. 2017 Jan 11;7:40006. doi: 10.1038/srep40006.

  17. Laisuan W, Wongsa C, Dchapaphapeaktak N, Tongdee M, Chatmapanrangsee J, Rerkpattanapipat T. Asia Pac Allergy. 2017 Apr;7(2):115-118. doi: 10.5415/apallergy.2017.7.2.115. Epub 2017 Apr 6. PMID: 28487843 Free PMC article. Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey.

  18. Ngamjanyaporn P, McCarthy EM, Sergeant JC, Reynolds J, Skeoch S, Parker B, Bruce IN. Lupus Sci Med. 2017 Jun 29;4(1):e000173. doi: 10.1136/lupus-2016-000173. eCollection 2017. PMID: 29238601 Free PMC article.

  19. Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity. Chiriac AM, Rerkpattanapipat T, Bousquet PJ, Molinari N, Demoly P. Allergy. 2017 Apr;72(4):552-561. doi: 10.1111/all.13037. Epub 2016 Nov 23. PMID: 27569064

  20. Successful Subcutaneous Allergen-Specific Immunotherapy in Refractory Atopic Keratoconjunctivitis: A Case Report. Jongkhajornpong P, Laisuan W. Case Rep Ophthalmol. 2017 Dec 14;8(3):562-567. doi: 10.1159/000485174. eCollection 2017 Sep-Dec. PMID: 29422859 Free PMC article.

  21. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. Maverakis E, Wang EA, Shinkai K, Mahasirimongkol S, Margolis DJ, Avigan M, Chung WH, Goldman J, La Grenade L, Pirmohamed M, Shear NH, Tassaeeyakul W, Hoetzenecker W, Klaewsongkram J, Rerkpattanapipat T, Manuyakorn W, Yasuda SU, Sharon VR, Sukhov A, Micheletti R, Struewing J, French LE, Cheng MY. JAMA Dermatol. 2017 Jun 1;153(6):587-592. doi: 10.1001/jamadermatol.2017.0160. PMID: 28296986 Free article.

  22. Fc Gamma Receptor IIB Deficient Mice: A Lupus Model with Increased Endotoxin Tolerance-Related Sepsis Susceptibility. Ondee T, Surawut S, Taratummarat S, Hirankarn N, Palaga T, Pisitkun P, Pisitkun T, Leelahavanichkul A. Shock. 2017 Jun;47(6):743-752. doi: 10.1097/SHK.0000000000000796. PMID: 27849678

  23. The role of macrophages in the susceptibility of Fc gamma receptor IIb deficient mice to Cryptococcus neoformans. Surawut S, Ondee T, Taratummarat S, Palaga T, Pisitkun P, Chindamporn A, Leelahavanichkul A. Sci Rep. 2017 Jan 11;7:40006. doi: 10.1038/srep40006.

2016

  1. In Vitro Test to Confirm Diagnosis of Allopurinol-Induced Severe Cutaneous Adverse Reactions. Klaewsongkram J, Thantiworasit P, Suthumchai N, Rerknimitr P, Sukasem C, Tuchinda P, Chularojanamontri L, Srinoulprasert Y, Rerkpattanapipat T, Chanprapaph K, Disphanurat W, Chakkavittumrong P, Tovanabutra N, Srisuttiyakorn C. Br J Dermatol. 2016 Nov;175(5):994-1002. doi: 10.1111/bjd.14701.
  2. FC Gamma Receptor IIB Deficient Mice: A Lupus Model with Increased Endotoxin Tolerance-Related Sepsis Susceptibility. Ondee T, Surawut S, Taratummarat S, Hirankan N, Palaga T, Pisitkun P, Pisitkun T, Leelahavanichkul A. Shock. 2016 Nov 15. [Epub ahead of print]
  3. Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity. Chiriac AM, Rerkpattanapipat T, Bousquet PJ, Molinari N, Demoly P. Allergy. 2016 Aug 29. doi: 10.1111/all.13037. [Epub ahead of print]
  4. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Reutrakul S, Thakkinstian A, Anothaisintawee T, Chontong S, Borel AL, Perfect MM, Janovsky CC, Kessler R, Schultes B, Harsch IA, van Dijk M, Bouhassira D, Matejko B, Lipton RB, Suwannalai P, Chirakalwasan N, Schober AK, Knutson KL. Sleep Med. 2016 Jul;23:26-45.
  5. Skin testing with β-lactam antibiotics for diagnosis of β-lactam hypersensitivity in children. Manuyakorn W, Singvijarn P, Benjaponpitak S, Kamchaisatian W, Rerkpattanapipat T, Sasisakulporn C, Jotikasthira W.Asian Pac J Allergy Immunol. 2016 Sep;34(3):242-247.
  6. Role of eosinophilic inflammation and atopy in elderly asthmatic patients. Kawamatawong T, Siripongpun S, Rerkpattanapipat T. Asia Pac Allergy. 2016 Jul;6(3):181-6.
  7. HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand. Sukasem C, Jantararoungtong T, Kuntawong P, Puangpetch A, Koomdee N, Satapornpong P, Supapsophon P, Klaewsongkram J, Rerkpattanapipat T. Front Pharmacol. 2016 Jul 18;7:186.
  8. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Katchamart W, Narongroeknawin P, Chevaisrakul P, Dechanuwong P, Mahakkanukrauh A, Kasitanon N, Pakchotanon R, Sumethkul K, Ueareewongsa P, Ukritchon S, Bhurihirun T, Duangkum K, Intapiboon P, Intongkam S, Jangsombatsiri W, Jatuworapruk K, Kositpesat N, Leungroongroj P, Lomarat W, Petcharat C, Sittivutworapant S, Suebmee P, Tantayakom P, Tipsing W, Asavatanabodee P, Chiowchanwisawakit P, Foocharoen C, Koolvisoot A, Louthrenoo W, Siripaitoon B, Totemchokchyakarn K, Kitumnuaypong T; Thai Rheumatism Association.. Int J Rheum Dis. 2016 Jul 25.
  9. The minor house dust mite allergen Der p 13 is a fatty acid binding protein and an activator of a TLR2-mediated innate immune response. Satitsuksanoa P, Kennedy M, Gilis D, Le Mignon M, Suratannon N, Wai TS, Wongpiyabovorn J, Chatchatee P, Vangveravong M, Rerkpattanapipat T, Sangasapaviliya A, Piboonpocanun S, Nony E, Ruxrungtham K, Jacquet A; Mite Allergy Research Cohort (MARC) study team. Allergy. 2016 Oct;71(10):1425-34. doi: 10.1111/all.12899. Epub 2016 Apr 29.
  10. Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. Tassaneeyakul W, Prabmeechai N, Sukasem C, Kongpan T, Konyoung P, Chumworathayi P, Tiamkao S, Khunarkornsiri U, Kulkantrakorn K, Saksit N, Nakkam N, Satapornpong P, Vannaprasaht S, Sangviroon A, Mahasirimongkol S, Wichukchinda N, Rerkpattanapipat T, Tassaneeyakul W. Pharmacogenet Genomics. 2016 May;26(5):225-34.
  11. Angiotensin-converting enzyme gene polymorphism in Thai patients with systemic lupus erythematosus. Pitipakorn U, Suwannalai P, Trachoo O, Rattanasiri S, Chitphuk S, Ngamjanyaporn P, Sura T. Int J Rheum Dis. 2016 Jul;19(7):693-9.
  12. Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis. Phuphuakrat A, Ngamjanyaporn P, Nantiruj K, Luangwedchakarn V, Malathum K. J Microbiol Immunol Infect. 2016 Feb;49(1):150-3.

2015

  1. Angiotensin-converting enzyme gene polymorphism in Thai patients with systemic lupus erythematosus. Pitipakorn U, Suwannalai P, Trachoo O, Rattanasiri S, Chitphuk S, Ngamjanyaporn P, Sura T. Int J Rheum Dis. 2016 Jul;19(7):693-9. doi: 10.1111/1756-185X.12609. Epub 2015 Jul 22.

  2. The House Dust Mite Major Allergen Der p 23 Displays O-Glycan-Independent IgE Reactivities but No Chitin-Binding Activity. Soh WT, Le Mignon M, Suratannon N, Satitsuksanoa P, Chatchatee P, Wongpiyaboron J, Vangveravong M, Rerkpattanapipat T, Sangasapaviliya A, Nony E, Piboonpocanun S, Ruxrungtham K, Jacquet A; Mite Allergy Research Cohort (MARC) Study Team. Int Arch Allergy Immunol. 2015;168(3):150-60. doi: 10.1159/000442176. Epub 2016 Jan 21.

  3. Granulomatosis with Polyangiitis: A Case of Nasal Mass, Necrotic Lung, and Normal Kidneys. Spanuchart I, Zungsontiporn N, O-charoen P, Changcharoen B, Bolger DT Jr. Hawaii J Med Public Health. 2015 Sep;74(9 Suppl 2):27-9. PMID: 26793412 Free PMC article.

  4. Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue. Benjachat T, Tongyoo P, Tantivitayakul P, Somparn P, Hirankarn N, Prom-On S, Pisitkun P, Leelahavanichkul A, Avihingsanon Y, Townamchai N. Int J Mol Sci. 2015 Jun 23;16(6):14276-90. doi: 10.3390/ijms160614276. PMID: 26110394 Free PMC article.

  5. Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection. Sun C, Schattgen SA, Pisitkun P, Jorgensen JP, Hilterbrand AT, Wang LJ, West JA, Hansen K, Horan KA, Jakobsen MR, O'Hare P, Adler H, Sun R, Ploegh HL, Damania B, Upton JW, Fitzgerald KA, Paludan SR. J Immunol. 2015 Feb 15;194(4):1819-31. doi: 10.4049/jimmunol.1402495. Epub 2015 Jan 16.

 

2014

  1. Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs. Wacharapornin P, Suwannalai P. J Med Assoc Thai. 2014 Nov;97(11):1157-63.
  2. IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Ha HL, Wang H, Pisitkun P, Kim JC, Tassi I, Tang W, Morasso MI, Udey MC, Siebenlist U.Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):E3422-31.
  3. Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia. Navarra SV, Tang B, Lu L, Lin HY, Mok CC, Asavatanabodee P, Suwannalai P, Hussein H, Rahman MU. Int J Rheum Dis. 2014 Mar;17(3):291-8.
  4. Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis. Suwannalai P, Britsemmer K, Knevel R, Scherer HU, Levarht EW, van der Helm-van Mil AH, van Schaardenburg D, Huizinga TW, Toes RE, Trouw LA. Ann Rheum Dis. 2014 Jan;73(1):270-6.

2013

  1. Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study. Zhong N, Lin J, Mehta P, Ngamjanyaporn P, Wu TC, Yunus F. BMC Pulm Med. 2013 Apr 4;13:22.
  2. Selective IgM deficiency in an adult presenting with Streptococcus pneumoniae septic arthritis. Phuphuakrat A, Ngamjanyaporn P, Nantiruj K, Luangwedchakarn V, Malathum K. J Microbiol Immunol Infect. 2016 Feb;49(1):150-3. doi: 10.1016/j.jmii.2013.01.009. Epub 2013 Mar 20.

2012

  1. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Pisitkun P, Ha HL, Wang H, Claudio E, Tivy CC, Zhou H, Mayadas TN, Illei GG, Siebenlist U. Immunity. 2012 Dec 14;37(6):1104-15. doi: 10.1016/j.immuni.2012.08.014.
  2. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Walsh ER, Pisitkun P, Voynova E, Deane JA, Scott BL, Caspi RR, Bolland S. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16276-81.
  3. Adverse drug events in rheumatoid arthritis and osteoarthritis ambulatory patients. Tragulpiankit P, Chulavatnatol S, Rerkpattanapipat T, Janwityanujit S, Somjarit S, Sirikhedgon U. Int J Rheum Dis. 2012 Jun;15(3):315-21.
  4. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Suwannalai P, Trouw LA, Toes RE, Huizinga TW. Mod Rheumatol. 2012 Feb;22(1):15-20.

2011

  1. Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand. Kiertiburanakul S, Suebsing S, Kehachindawat P, Apivanich S, Somsakul S, Sathapatayavongs B, Malathum K. J Hosp Infect. 2011 Dec 20.

  2. Optimal timing of antiretroviral therapy initiation in patients coinfected with HIV and tuberculosis.Kiertiburanakul S, Manosuthi W, Sungkanuparph S. Expert Rev Clin Pharmacol. 2011 Mar;4(2):143-6.

  3. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP. J Infect. 2012 Jan;64(1):68-75. Epub 2011 Nov 11.

  4. Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients. Anekthananon T, Manosuthi W, Chetchotisakd P, Kiertiburanakul S, Supparatpinyo K, Ratanasuwan W, Pappas PG, Filler SG, Kopetskie HA, Nolen TL, Kendrick AS, Larsen RA; BAMSG 3-01 Study Team. Int J STD AIDS. 2011 Nov;22(11):665-70.

  5. GM-CSF Fails to Improve Immune Responses to Booster Hepatitis B Vaccination in HIV-Infected Individuals.Overton ET, Sungkanuparph S, Klebert M, Royal M, Demarco-Shaw D, Powderly WG, Aberg JA. Open Virol J. 2011;5:109-13. Epub 2011 Oct 14.

  6. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens.Bunupuradah T, Ananworanich J, Chetchotisakd P, Kantipong P, Jirajariyavej S, Sirivichayakul S, Munsakul W, Prasithsirikul W, Sungkanuparph S, Bowonwattanuwong C, Klinbuayaem V, Petoumenos K, Hirschel B, Bhakeecheep S, Ruxrungtham K. Antivir Ther. 2011;16(7):1113-21.

  7. HIV Type 1 Integrase Polymorphisms in Treatment-Naive and Treatment-Experienced HIV Type 1-Infected Patients in Thailand Where HIV Type 1 Subtype A/E Predominates.Phuphuakrat A, Pasomsub E, Kiertiburanakul S, Chantratita W, Sungkanuparph S. AIDS Res Hum Retroviruses. 2011 Nov 22.

  8. Primary Prophylaxis for Pneumocystis jirovecii Pneumonia in Patients with Connective Tissue Diseases.Vananuvat P, Suwannalai P, Sungkanuparph S, Limsuwan T, Ngamjanyaporn P, Janwityanujit S. Semin Arthritis Rheum. 2011 Dec;41(3):497-502. Epub 2011 Sep 29.

  9. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.Kanchana S, Kanchana S, Chuntrakul C, Malathum K, Prachayangprecha S, Poovorawan Y. J Infect. 2011 Oct;63(4):295-9. Epub 2011 Aug 9.

  10. Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?McManus H, Li PC, Nolan D, Bloch M, Kiertiburanakul S, Choi JY, Mulhall B, Petoumenos K, Zhou J, Law M, Brew BJ, Wright E. HIV Med. 2011 Nov;12(10):610-9. Epub 2011 Aug 7.

  11. Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Takahashi A, Kubo M, Kamatani N, Chantratita W, Nakamura Y. Clin Infect Dis. 2011 Aug;53(4):341-8.

  12. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting. Manosuthi W, Prasithsirikul W, Tantanathip P, Chimsuntorn S, Nilkamhang S, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2011 May;42(3):643-50.

  13. Simultaneous detection and subtyping of H274Y-positive influenza A (H1N1) using pyrosequencing.Chantratita W, Sukasem C, Sirinavin S, Sankuntaw N, Srichantaratsamee C, Pasomsub E, Malathum K. J Infect Dev Ctries. 2011 May 28;5(5):348-52.

  14. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand.Kiertiburanakul S, Malathum K, Watcharananan SP, Bunupuradah P, Piebpien P, Rujiraviroj U, Likitsinsipon W, Apivanich S, Kehachindawat P, Burakitcharoen R, Leelaudomlipi S, Wananukul W. Am J Infect Control. 2011 Aug;39(6):525-8. Epub 2011 May 25.

  15. Monitoring of Renal Function among HIV-Infected Patients Receiving Tenofovir in a Resource-Limited Setting.Kiertiburanakul S, Chaisiri K, Kasettratat N, Visuttimak P, Bowonwatanuwong C. J Int Assoc Physicians AIDS Care (Chic). 2011 Sep-Oct;10(5):297-302. Epub 2011 May 23.

  16. Serum antioxidant levels and nutritional status in early and advanced stage lung cancer patients.Klarod K, Hongsprabhas P, Khampitak T, Wirasorn K, Kiertiburanakul S, Tangrassameeprasert R, Daduang J, Yongvanit P, Boonsiri P. Nutrition. 2011 Nov-Dec;27(11-12):1156-60. Epub 2011 May 6.

  17. Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD). Han SH, Zhou J, Saghayam S, Vanar S, Phanuphak N, Chen YM, Sirisanthana T, Sungkanuparph S, Lee CK, Pujari S, Li PC, Oka S, Saphonn V, Zhang F, Merati TP, Law MG, Choi JY; TREAT Asia HIV Observational Database. Endocr J. 2011;58(6):475-84. Epub 2011 Apr 27.

  18. HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P; TREAT Asia Studies to Evaluate Resistance-Monitoring Study (TASER-M). Clin Infect Dis. 2011 Apr 15;52(8):1053-7.

  19. Adenovirus disease after kidney transplantation: course of infection and outcome in relation to blood viral load and immune recovery. Watcharananan SP, Avery R, Ingsathit A, Malathum K, Chantratita W, Mavichak V, Chalermsanyakorn P, Jirasiritham S, Sumethkul V. Am J Transplant. 2011 Jun;11(6):1308-14. Epub 2011 Mar 30.

  20. Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: a prospective study. Manosuthi W, Lueangniyomkul A, Mankatitham W, Chimsuntorn S, Tantanathip P, Thongyen S, Suntisuklappon B, Nilkamhang S, Sungkanuparph S. J Infect. 2011 May;62(5):406-9. Epub 2011 Mar 5.

  21. Virologic and Immunologic Outcomes of the Second-Line Regimens of Antiretroviral Therapy Among HIV-Infected Patients in Thailand. Win MM, Maek-A-Nantawat W, Phonrat B, Kiertiburanakul S, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb;10(1):57-63.

  22. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, Woeltje KF, Fraser VJ. Int J Tuberc Lung Dis. 2011 Jan;15(1):14-23. Review.

  23. Single-Boosted Protease Inhibitor versus Double-Boosted Protease Inhibitors for the Salvage Therapy in HIV-Infected Patients. Manosuthi W, Chimsuntorn S, Thongyen S, Nilkamhang S, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2011 Mar-Apr;10(2):105-10. Epub 2011 Jan 24.

  24. Late and low compliance with hepatitis B serology screening among HIV-infected patients in a resource-limited setting: an issue to improve HIV care. Kiertiburanakul S, Chotiprasitsakul D, Atamasirikul K, Sungkanuparph S. Curr HIV Res. 2011 Jan 1;9(1):54-60.

    1. Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, Vugt MV, Rinke de Wit TF; on behalf of the PharmAccess African (PASER) and TREAT Asia (TASER) Studies to Evaluate Resistance. Int J Epidemiol. 2011 Apr 21.
  25. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA).Wisniewski T, Klimko N, Laverdiere M, Kiertiburanakul S, Kliasova G, Trenschel R, Kumar RN. Mycoses. 2011 Jul;54(4):e148-53. Epub 2010 Feb 24.

2010

  1. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. Zhou J, Sirisanthana T, Kiertiburanakul S, Chen YM, Han N, Lim PL, Kumarasamy N, Choi JY, Merati TP, Yunihastuti E, Oka S, Kamarulzaman A, Phanupak P, Lee CK, Li PC, Pujari S, Saphonn V, Law MG. BMC Infect Dis. 2010 Dec 23;10(1):361.
  2. Adenovirus infection after kidney transplantation in Thailand: seasonal distribution and potential route of acquisition. Watcharananan SP, Junchotikul P, Srichanrusmi C, Chanchompoo P, Mavichak V, Kantachuvessiri S, Chantratita W. Transplant Proc. 2010 Dec;42(10):4091-3.
  3. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors. Petoumenos K, Hui E, Kumarasamy N, Kerr SJ, Choi JY, Chen YM, Merati T, Zhang F, Lim PL, Sungkanuparph S, Pujari S, Ponnampalavanar S, Ditangco R, Lee CK, Grulich A, Law MG, Asia Hiv Observational Database T. J Int AIDS Soc. 2010 Dec 10;13(1):51.
  4. Prevalence of and risk factors for pre-diabetes in HIV-1-infected patients in Bangkok, Thailand. Srivanich N, Ngarmukos C, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic). 2010 Nov-Dec;9(6):358-61. Epub 2010 Nov 12.
  5. Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight. Chaisiri K, Bowonwatanuwong C, Kasettratat N, Kiertiburanakul S.Curr HIV Res. 2010 Oct 1;8(7):504-9.
  6. Rhinofacial entomophthoramycosis; a case series and review of the literature. Leopairut J, Larbcharoensub N, Cheewaruangroj W, Sungkanuparph S, Sathapatayavongs B.Southeast Asian J Trop Med Public Health. 2010 Jul;41(4):928-35. Review.
  7. Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, Vugt MV, Rinke de Wit TF; on behalf of the PharmAccess African (PASER) and TREAT Asia (TASER) Studies to Evaluate Resistance.Int J Epidemiol. 2010 Nov 10.
  8. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR; International Network for the Study of HIV-associated IRIS (INSHI). Lancet Infect Dis. 2010 Nov;10(11):791-802.
  9. Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens. Manosuthi W, Mankatitham W, Lueangniyomkul A, Prasithsirikul W, Tantanathip P, Suntisuklappon B, Narkksoksung A, Nilkamhang S, Sungkanuparph S. AIDS Res Ther. 2010 Oct 11;7:37.
  10. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study. Manosuthi W, Tantanathip P, Chimsuntorn S, Eampokarap B, Thongyen S, Nilkamhang S, Sungkanuparph S. Int J Infect Dis. 2010 Nov;14(11):e1013-7. Epub 2010 Sep 28.
  11. Intravascular B-cell lymphoma presenting with cauda equina syndrome: the role of skin biopsy. Piyatanont K, Bamrungrak K, Watcharananan S, Sathapatayavongs B, Chuncharunee S, Larbcharoensub N, Witoonpanich R. Eur J Dermatol. 2010 Nov-Dec;20(6):821-2. Epub 2010 Sep 27.
  12. Epidemiology and risk factors of catheter-associated bloodstream infections among intensive care unit patients: an experience from a tertiary care hospital in Thailand. Kiertiburanakul S, Apivanich S, Muntajit T, Somsakul S, Malathum K. J Hosp Infect. 2010 Dec;76(4):369-71. Epub 2010 Sep 17.
  13. Comparison of protease inhibitor (PI) resistance-associated mutations between PI-naïve and PI-experienced HIV-1 infected patients in Thailand Where subtype A/E is predominant. Wiboonchutikul S, Sungkanuparph S, Sukasem C, Wathipthun C, Chantratita W. Curr HIV Res. 2010 Sep 1;8(6):456-60.
  14. Cytomegalovirus, adenovirus, and polyomavirus co-infection among pediatric recipients of allogeneic stem cell transplantation: characteristics and outcome. Watcharananan SP, Kiertiburanakul S, Piyatuctsanawong W, Anurathapan U, Sungkanuparph S, Pakakasama S, Chantratita W, Hongeng S. Pediatr Transplant. 2010 Aug;14(5):675-81. Epub 2010 Apr 13.
  15. Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy. Wongprasit P, Manosuthi W, Kiertiburanakul S, Sungkanuparph S. AIDS Patient Care STDS. 2010 Apr;24(4):205-9.
  16. Mortality rates in HIV-infected patients with second failure of antiretroviral therapy are still high: a lesson from NA-ACCORD. Sungkanuparph S. Expert Rev Anti Infect Ther. 2010 Apr;8(4):371-3.
  17. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. Pongsai P, Atamasirikul K, Sungkanuparph S. J Infect. 2010 Jun;60(6):474-7. Epub 2010 Mar 27.
  18. Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD). Oyomopito R, Lee MP, Phanuphak P, Lim PL, Ditangco R, Zhou J, Sirisanthana T, Chen YM, Pujari S, Kumarasamy N, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang FJ, Mean CV, Merati T, Tau G, Smith J, Li PC; TREAT Asia HIV Observational Database. HIV Med. 2010 Sep;11(8):519-29. Epub 2010 Mar 21.
  19. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems. Pasomsub E, Sukasem C, Sungkanuparph S, Kijsirikul B, Chantratita W. Jpn J Infect Dis. 2010 Mar;63(2):87-94.
  20. Immune reconstitution inflammatory syndrome in HIV-infected patients with tuberculosis. Kiertiburanakul S. J Med Assoc Thai. 2010 Feb;93(2):257-64. Review.
  21. Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA). Wisniewski T, Klimko N, Laverdiere M, Kiertiburanakul S, Kliasova G, Trenschel R, Kumar RN. Mycoses. 2010 Feb 24.
  22. Using of nevirapine is associated with intermediate and reduced response to etravirine among HIV-infected patients who experienced virologic failure in a resource-limited setting. Kiertiburanakul S, Wiboonchutikul S, Sukasem C, Chantratita W, Sungkanuparph S. J Clin Virol. 2010 Apr;47(4):330-4. Epub 2010 Feb 25.
  23. H1N1 2009 influenza among healthcare workers in a tertiary care hospital in Thailand. Kiertiburanakul S, Apivanich S, Muntajit T, Sukkra S, Sirinavin S, Leelaudomlipi S, Wananukul W, Satapattayavong B, Malathum K. J Hosp Infect. 2010 Mar;74(3):300-2. Epub 2010 Feb 10.
  24. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure. Watcharananan SP, Suwatanapongched T, Wacharawanichkul P, Chantratitaya W, Mavichak V, Mossad SB. Transpl Infect Dis. 2010 Apr;12(2):127-31. Epub 2010 Jan 20.
  25. Association between HLA-B*4001 and lipodystrophy among HIV-infected patients from Thailand who received a stavudine-containing antiretroviral regimen. Wangsomboonsiri W, Mahasirimongkol S, Chantarangsu S, Kiertiburanakul S, Charoenyingwattana A, Komindr S, Thongnak C, Mushiroda T, Nakamura Y, Chantratita W, Sungkanuparph S. Clin Infect Dis. 2010 Feb 15;50(4):597-604.
  26. Successful Viral Suppression With Subsequent Efavirenz-Based Regimen in HIV-1-Infected Patients Who Stop Nevirapine Prior to Discontinuation of the NRTI Backbone. Chimsuntorn S, Sungkanuparph S, Manosuthi W. J Int Assoc Physicians AIDS Care (Chic). 2010 Jan-Feb;9(1):43-5.
  27. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. Manosuthi W, Chetchotisakd P, Nolen TL, Wallace D, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Pappas PG, Larsen RA, Filler SG, Andes D; BAMSG 3-01 Study Team. HIV Med. 2010 Apr;11(4):276-81. Epub 2009 Dec 8.
  28. Rapid influenza diagnostic test during the outbreak of the novel influenza A/H1N1 2009 in Thailand: an experience with better test performance in resource limited setting. Watcharananan S, Kiertiburanakul S, Chantratita W. J Infect. 2010 Jan;60(1):86-7. Epub 2009 Oct 27.
  29. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). Zhou J, Li PC, Kumarasamy N, Boyd M, Chen YM, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang FJ, Omar SF, Lee CK, Ditangco R, Merati TP, Lim PL, Choi JY, Law MG, Pujari S; TREAT Asia HIV Observational Database. HIV Med. 2010 Jan;11(1):31-9. Epub 2009 Jul 6.

2009

  1. Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure. Manosuthi W, Kiertiburanakul S, Amornnimit W, Prasithsirikul W, Thongyen S, Nilkamhang S, Ruxrungtham K, Sungkanuparph S. AIDS Res Ther. 2009 Dec 23;6(1):30.

  2. Monitoring and impact of fluconazole serum and cerebrospinal fluid concentration in HIV-associated cryptococcal meningitis-infected patients. Manosuthi W, Chetchotisakd P, Nolen T, Wallace D, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Pappas P, Larsen R, Filler S, Andes D; on behalf of the BAMSG 3-01 Study Team. HIV Med.

  3. Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. Manosuthi W, Van Tieu H, Mankatitham W, Lueangniyomkul A, Ananworanich J, Avihingsanon A, Siangphoe U, Klongugkara S, Likanonsakul S, Thawornwan U, Suntisuklappon B, Sungkanuparph S; N2R Study Team.AIDS. 2009 Nov 27;23(18):2467-71.

  4. The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients. Nüesch R, Gayet-Ageron A, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Chautrakarn S, Ruxrungtham K, Hirschel B, Anaworanich J; STACCATO study group. Open AIDS J. 2009 Sep 15;3:38-45.

  5. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study. Sungkanuparph S, Filler SG, Chetchotisakd P, Pappas PG, Nolen TL, Manosuthi W, Anekthananon T, Morris MI, Supparatpinyo K, Kopetskie H, Kendrick AS, Johnson PC, Sobel JD, Larsen RA. Clin Infect Dis. 2009 Sep 15;49(6):931-4.

  6. Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin. Manosuthi W, Sungkanuparph S, Tantanathip P, Mankatitham W, Lueangniyomkul A, Thongyen S, Eampokarap B, Uttayamakul S, Suwanvattana P, Kaewsaard S, Ruxrungtham K; N2R Study Team. Antimicrob Agents Chemother. 2009 Oct;53(10):4545-8.

  7. A model and risk score for predicting nevirapine-associated rash among HIV-infected patients: in settings of low CD4 cell counts and resource limitation. Kiertiburanakul S, Sungkanuparph S, Malathum K, Watcharananan S, Sathapatayavongs B, Charoenyingwattana A, Mahasirimongkol S, Chantratita W. Open AIDS J. 2009 Jul 8;3:24-30.

  8. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD). Zhou J, Li P, Kumarasamy N, Boyd M, Chen Y, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang F, Omar S, Lee C, Ditangco R, Merati T, Lim P, Choi J, Law M, Pujari S; on behalf of the TREAT Asia HIV Observational Database. HIV Med. 2009 Jul 6.

  9. Effect of high-dose fluconazole on QT interval in patients with human immunodeficiency virus (HIV)-associated cryptococcal meningitis. Manosuthi W, Sungkanuparph S, Anekthananon T, Supparatpinyo K, Nolen TL, Zimmer LO, Pappas PG, Larsen RA, Filler SG, Chetchotisakd P; BAMSG 3-01 Study Team. Int J Antimicrob Agents. 2009 Nov;34(5):494-6.

  10. Emerging of HIV drug resistance: epidemiology, diagnosis, treatment and prevention. Kiertiburanakul S, Sungkanuparph S. Curr HIV Res. 2009 May;7(3):273-8.

  11. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris MI, Anekthananon T, Sungkanuparph S, Supparatpinyo K, Nolen TL, Zimmer LO, Kendrick AS, Johnson P, Sobel JD, Filler SG. Clin Infect Dis. 2009 Jun 15;48(12):1775-83.

  12. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study. Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K; N2R Study Team. Clin Infect Dis. 2009 Jun 15;48(12):1752-9.

  13. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region. Hsueh PR, Graybill JR, Playford EG, Watcharananan SP, Oh MD, Ja'alam K, Huang S, Nangia V, Kurup A, Padiglione AA. Int J Antimicrob Agents. 2009 Sep;34(3):205-9.

  14. Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD). Egger S, Petoumenos K, Kamarulzaman A, Hoy J, Sungkanuparph S, Chuah J, Falster K, Zhou J, Law MG; Asia Pacific HIV Observational Database (APHOD). J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):513-20.

  15. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, Pujari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang F, Tau G, Ditangco R. BMC Infect Dis. 2009 Apr 21;9:46.

  16. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Sungkanuparph S, Apiwattanakul N, Thitithanyanont A, Chantratita W, Sirinavin S. Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):83-8.

  17. Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash. Kiertiburanakul S, Malathum K, Watcharananan S, Sathapatayavongs B, Sungkanuparph S. Int J STD AIDS. 2009 Mar;20(3):176-9.

  18. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Clin Infect Dis. 2009 Apr 1;48(7):940-50.

  19. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients. Chantarangsu S, Mushiroda T, Mahasirimongkol S, Kiertiburanakul S, Sungkanuparph S, Manosuthi W, Tantisiriwat W, Charoenyingwattana A, Sura T, Chantratita W, Nakamura Y. Pharmacogenet Genomics. 2009 Feb;19(2):139-46.

2008

  1. A study of seven rule-based algorithms for the interpretation of HIV-1 genotypic resistance data in Thailand. Poonpiriya V, Sungkanuparph S, Leechanachai P, Pasomsub E, Watitpun C, Chunhakan S, Chantratita W. J Virol Methods. 2008 Jul;151(1):79-86. Epub 2008 May 6.

  2. Clinical Presentations of Newly Diagnosed HIV-Infected Patients at a University Hospital in Bangkok, Thailand. Kiertiburanakul S, Boonyarattaphun K, Atamasirikul K, Sungkanuparph S. J Int Assoc Physicians AIDS Care (Chic Ill). 2008 Jun;7(2):82-7. Epub 2008 Mar 4.

  3. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients. Jongwutiwes U, Sungkanuparph S, Kiertiburanakul S. Jpn J Infect Dis. 2008 Mar;61(2):111-5.

  4. Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting. Sungkanuparph S, Wongprasit P, Manosuthi W, Atamasirikul K. Southeast Asian J Trop Med Public Health. 2008 Sep;39(5):863-6.

  5. Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study. Manosuthi W, Tantanathip P, Prasithisirikul W, Likanonsakul S, Sungkanuparph S. BMC Infect Dis. 2008 Oct 14;8:136.

  6. Effect of Postpartum HIV Treatment Discontinuation on Long-Term Maternal Outcome. Onen NF, Nurutdinova D, Sungkanuparph S, Gase D, Mondy K, Overton ET. J Int Assoc Physicians AIDS Care (Chic Ill). 2008 Sep-Oct;7(5):245-51. Epub 2008 Sep 23.

  7. Evaluating the role of etravirine in the second-line antiretroviral therapy after failing an initial non-nucleoside reverse transcriptase inhibitor-based regimen in a resource-limited setting. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chantratita W. Curr HIV Res. 2008 Sep;6(5):474-6.

  8. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL. Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chaovavanich A. J Med Assoc Thai. 2008 Feb;91(2):159-65.

  9. Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. Ananworanich J, Gayet-Ageron A, Ruxrungtham K, Chetchotisakd P, Prasithsirikul W, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, LeBraz M, Jupimai T, Ubolyam S, Schutz M, Hirschel B; Staccato Thailand Study Group. Antivir Ther. 2008;13(3):375-80.

  10. Mortality rate of early versus deferred initiation of antiretroviral therapy in HIV-1-infected patients with cryptococcal meningitis. Manosuthi W, Chottanapund S, Sungkanuparph S. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):508-9. No abstract available.

  11. Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir. Manosuthi W, Sungkanuparph S, Ruxrungtham K, Prasithsirikul W, Athichathanabadi C, Tantisiriwat W, Bowonwatanuwong C, Chumpathat N, Chaovavanich A. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):127-9. No abstract available.

  12. Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapine. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Saekang N, Pairoj W, Chantratita W. J Clin Virol. 2008 Apr;41(4):310-3. Epub 2008 Mar 7.

  13. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting. Manosuthi W, Prasithsirikul W, Chumpathat N, Suntisuklappon B, Athichathanabadi C, Chimsuntorn S, Sungkanuparph S. Int J Infect Dis. 2008 Nov;12(6):582-6. Epub 2008 Mar 11.

  14. Risk factors for nevirapine-associated rash among HIV-infected patients with low CD4 cell counts in resource-limited settings. Kiertiburanakul S, Sungkanuparph S, Charoenyingwattana A, Mahasirimongkol S, Sura T, Chantratita W. Curr HIV Res. 2008 Jan;6(1):65-9.

  15. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin. Manosuthi W, Mankatitham W, Lueangniyomkul A, Chimsuntorn S, Sungkanuparph S. HIV Med. 2008 May;9(5):294-9.

  16. Streptococcus suis infection and risk factors for mortality. Wangsomboonsiri W, Luksananun T, Saksornchai S, Ketwong K, Sungkanuparph S. J Infect. 2008 Nov;57(5):392-396. Epub 2008 Oct 2.

  17. Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis. Manosuthi W, Sungkanuparph S, Chottanapund S, Tansuphaswadikul S, Chimsuntorn S, Limpanadusadee P, Pappas PG. Int J STD AIDS. 2008 Apr;19(4):268-71.

  18. Tipranavir resistance associated mutations in protease inhibitor-naïve patients with HIV-1 subtype A/E infection. Sungkanuparph S, Sukasem C, Manosuthi W, Wiboonchutikul S, Piyavong B, Chantratita W. J Clin Virol. 2008 Nov;43(3):284-6. Epub 2008 Aug 13.

2007

  1. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome. Sungkanuparph S, Chakriyanuyok T, Butthum B. J Infect. 2008 Jan;56(1):40-3. Nov 26.

  2. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. Sungkanuparph S, Eampokalap B, Chottanapund S, Bed ST, Manosuthi W. J Med Assoc Thai. 2007 May;90(5):884-8.

  3. Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand. Chetchotisakd P, Kiertiburanakul S, Mootsikapun P, Assanasen S, Chaiwarith R, Anunnatsiri S. Clin Infect Dis. 2007 Aug 15;45(4):421-7.

  4. Efficacy and tolerability of a double boosted protease inhibitor (lopinavir + saquinavir/ritonavir) regimen in HIV-infected patients who failed treatment with nonnucleoside reverse transcriptase inhibitors. Chetchotisakd P, Anunnatsiri S, Mootsikapun P, Kiertiburanakul S, Anekthananon T, Bowonwatanuwong C, Kowadisaiburana B, Supparatpinyo K, Ruxrungtham K; Study Team. HIV Med. 2007 Nov;8(8):529-35.

  5. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients. Kiertiburanakul S, Khongnorasat S, Rattanasiri S, Sungkanuparph S. J Med Assoc Thai. 2007 Feb;90(2):237-43.

  6. Factors for predicting successful immune response to hepatitis B vaccination in HIV-1 infected patients. Ungulkraiwit P, Jongjirawisan Y, Atamasirikul K, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):680-5.

  7. HIV-1 genotype after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and virological response after resumption of the same regimen. Sungkanuparph S, Kiertiburanakul S, Apisarnthanarak A, Malathum K, Sathapatayavongs B. Int J STD AIDS. 2007 Dec;18(12):832-4.

  8. Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection. Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Curr HIV Res. 2007 May;5(3):355-60.

  9. Impact of drug-resistant tuberculosis on the survival of HIV-infected patients. Sungkanuparph S, Eampokalap B, Chottanapund S, Thongyen S, Manosuthi W. Int J Tuberc Lung Dis. 2007 Mar;11(3):325-30.

  10. Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. Manosuthi W, Chaovavanich A, Tansuphaswadikul S, Prasithsirikul W, Inthong Y, Chottanapund S, Sittibusaya C, Moolasart V, Termvises P, Sungkanuparph S. J Infect. 2007 Nov;55(5):464-9.

  11. Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL. Manosuthi W, Sungkanuparph S, Tansuphaswadikul S, Inthong Y, Prasithsirikul W, Chottanapund S, Mankatitham W, Chimsuntorn S, Sittibusaya C, Moolasart V, Chumpathat N, Termvises P, Chaovavanich A. Int J STD AIDS. 2007 Nov;18(11):782-6.

  12. Incidence and time trend of surgical site infection in Ramathibodi Hospital during the years 2003-2005. Kehachindawat P, Malathum K, Boonsaeng K, Siripornpinyo N, Bhumisirikul P, Kolkalkul J, Lertsithichai P. J Med Assoc Thai. 2007 Jul;90(7):1356-62.

  13. Invasive aspergillosis in a tertiary-care hospital in Thailand. Kiertiburanakul S, Thibbadee C, Santanirand P. J Med Assoc Thai. 2007 May;90(5):895-902.

  14. Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. Jongjirawisan Y, Ungulkraiwit P, Sungkanuparph S. J Med Assoc Thai. 2006 Dec;89(12):2028-34.

  15. Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy. Chuapai Y, Kiertiburanakul S, Malathum K, Sungkanuparph S. J Med Assoc Thai. 2007 Mar;90(3):452-8.

  16. Logistic regression analysis to predict Medical Licensing Examination of Thailand (MLET) Step1 success or failure. Wanvarie S, Sathapatayavongs B. Ann Acad Med Singapore. 2007 Sep;36(9):770-3.

  17. Malignancies in HIV-infected Thai patients. Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S. HIV Med. 2007 Jul;8(5):322-3.

  18. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis. Manosuthi W, Ruxrungtham K, Likanonsakul S, Prasithsirikul W, Inthong Y, Phoorisri T, Sungkanuparph S. Clin Infect Dis. 2007 Jan 1;44(1):141-4.

  19. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Clin Infect Dis. 2007 Feb 1;44(3):447-52.

  20. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients. Manosuthi W, Kiertiburanakul S, Chaovavanich A, Sungkanuparph S. J Med Assoc Thai. 2007 Feb;90(2):244-50.

  21. Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole. Manosuthi W, Athichathanabadi C, Uttayamakul S, Phoorisri T, Sungkanuparph S. BMC Infect Dis. 2007 Mar 12;7:14.

  22. Predictors of immunity after hepatitis A vaccination in HIV-infected persons. Overton ET, Nurutdinova D, Sungkanuparph S, Seyfried W, Groger RK, Powderly WG. J Viral Hepat. 2007 Mar;14(3):189-93.

  23. Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting. Sungkanuparph S, Kiertiburanakul S, Apisarnthanarak A, Malathum K, Watcharananan S, Sathapatayavongs B. AIDS Res Ther. 2007 Nov 21;4:26.

  24. Risk factors for strongyloidiasis hyperinfection and clinical outcomes. Asdamongkol N, Pornsuriyasak P, Sungkanuparph S. Southeast Asian J Trop Med Public Health. 2006 Sep;37(5):875-84.

  25. Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 > or = 50 cells/mm3. Manosuthi W, Chimsuntorn S, Likanonsakul S, Sungkanuparph S. AIDS Res Ther. 2007 Mar 13;4:6.

  26. Tenofovir resistance among HIV-infected patients failing a fixed-dose combination of stavudine, lamivudine, and nevirapine in a resource-limited setting. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Chantratitra W. AIDS Patient Care STDS. 2007 Oct;21(10):711-4.

    1. of cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in patients with AIDS and cryptococcal meningitis. Sungkanuparph S, Jongwutiwes U, Kiertiburanakul S. J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):595-6.

2006

  1. Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir. Ananworanich J, Hirschel B, Sirivichayakul S, Ubolyam S, Jupimai T, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Schutz M, Snowden W, Ruxrungtham K; Staccato Study Team. Antivir Ther. 2006;11(5):631-5.

  2. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis. Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S. J Med Assoc Thai. 2006 Jun;89(6):795-802.

  3. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Ananworanich J, Gayet-Ageron A, Le Braz M, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawasdikul S, Sirivichayakul S, Cavassini M, Karrer U, Genné D, Nüesch R, Vernazza P, Bernasconi E, Leduc D, Satchell C, Yerly S, Perrin L, Hill A, Perneger T, Phanuphak P, Furrer H, Cooper D, Ruxrungtham K, Hirschel B; Staccato Study Group; Swiss HIV Cohort Study. Lancet. 2006 Aug 5;368(9534):459-65.

  4. Clinical and epidemiological analyses of human pythiosis in Thailand. Krajaejun T, Sathapatayavongs B, Pracharktam R, Nitiyanant P, Leelachaikul P, Wanachiwanawin W, Chaiprasert A, Assanasen P, Saipetch M, Mootsikapun P, Chetchotisakd P, Lekhakula A, Mitarnun W, Kalnauwakul S, Supparatpinyo K, Chaiwarith R, Chiewchanvit S, Tananuvat N, Srisiri S, Suankratay C, Kulwichit W, Wongsaisuwan M, Somkaew S. Clin Infect Dis. 2006 Sep 1;43(5):569-76.

  5. Cryptococcosis in human immunodeficiency virus-negative patients. Kiertiburanakul S, Wirojtananugoon S, Pracharktam R, Sungkanuparph S. Int J Infect Dis. 2006 Jan;10(1):72-8.

  6. Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results. Manosuthi W, Kiertiburanakul S, Sungkanuparph S, Ruxrungtham K, Vibhagool A, Rattanasiri S, Thakkinstian A. AIDS. 2006 Jan 2;20(1):131-2.

  7. Evidence-based medicine in clinical curriculum. Wanvarie S, Sathapatayavongs B, Sirinavin S, Ingsathit A, Ungkanont A, Sirinan C. Ann Acad Med Singapore. 2006 Sep;35(9):615-8.

  8. High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant. Chetchotisakd P, Anunnatsiri S, Kiertiburanakul S, Sutthent R, Anekthananon T, Bowonwatanuwong C, Kowadisaiburana B, Supparatpinyo K, Horsakulthai M, Chasombat S, Ruxrungtham K; Study Team. J Int Assoc Physicians AIDS Care (Chic Ill). 2006 Dec;5(4):152-6.

  9. Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational Database. Zhou J, Phanupak P, Kiertiburanakul S, Ditangco R, Kamarulzaman A, Pujary S; TREAT Asia HIV Observational Database. J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):501-3.

  10. Identification of a novel 74-kiloDalton immunodominant antigen of Pythium insidiosum recognized by sera from human patients with pythiosis. Krajaejun T, Kunakorn M, Pracharktam R, Chongtrakool P, Sathapatayavongs B, Chaiprasert A, Vanittanakom N, Chindamporn A, Mootsikapun P. J Clin Microbiol. 2006 May;44(5):1674-80.

  11. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. J Infect. 2006 Dec;53(6):357-63.

  12. Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash. Manosuthi W, Thongyen S, Chumpathat N, Muangchana K, Sungkanuparph S. HIV Med. 2006 Sep;7(6):378-82.

  13. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A. J Infect. 2006 Mar;52(3):188-94.

  14. Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. Sungkanuparph S, Groger RK, Overton ET, Fraser VJ, Powderly WG. HIV Med. 2006 Oct;7(7):437-41.

  15. Plasma nevirapine levels and 24-week efficacy in HIV-infected patients receiving nevirapine-based highly active antiretroviral therapy with or without rifampicin. Manosuthi W, Sungkanuparph S, Thakkinstian A, Rattanasiri S, Chaovavanich A, Prasithsirikul W, Likanonsakul S, Ruxrungtham K. Clin Infect Dis. 2006 Jul 15;43(2):253-5.

  16. Prevalence of thyroid dysfunction in Thai HIV-infected patients. Ketsamathi C, Jongjaroenprasert W, Chailurkit LO, Udomsubpayakul U, Kiertiburanakul S. Curr HIV Res. 2006 Oct;4(4):463-7.

  17. Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. J Acquir Immune Defic Syndr. 2006 Sep;43(1):42-6.

  18. Tolerability of HIV postexposure prophylaxis among healthcare workers. Kiertiburanakul S, Wannaying B, Tonsuttakul S, Kehachindawat P, Apivanich S, Somsakul S, Malathum K. J Hosp Infect. 2006 Jan;62(1):112-4.

  19. Virological and immunological responses of efavirenz-based HAART regimen initiated in HIV-infected patients at CD4 < 100 versus CD4 > or = 100 cells/mm3. Kiertiburanakul S, Sungkanuparph S, Rattanasiri S, Manosuthi W, Vibhagool A, Thakkinstian A. J Med Assoc Thai. 2006 Sep;89(9):1381-7.

2005

  1. A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. Ananworanich J, Hill A, Siangphoe U, Ruxrungtham K, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Raksakulkarn P, Tansuphasawadikul S, Nuesch R, Cooper DA, Hirschel B; Staccato Study Group. Antivir Ther. 2005;10(6):761-7.

  2. Antiretroviral resistance among HIV-positive pregnant women who have antiretroviral experience from previous pregnancy. Overton ET, Sungkanuparph S, Nurutdinova D, Powderly WG. AIDS. 2005 Sep 2;19(13):1439.

  3. Chronic neck ulcer in an immunocompetent host. Manosuthi W, Malathum K, Sungkanuparph S, Laothamatah J, Vorachit M, Nitiyanant P. Lancet Infect Dis. 2005 Mar;5(3):190. No abstract available.

  4. Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin. Manosuthi W, Sungkanuparph S, Thakkinstian A, Vibhagool A, Kiertiburanakul S, Rattanasiri S, Prasithsirikul W, Sankote J, Mahanontharit A, Ruxrungtham K. AIDS. 2005 Sep 23;19(14):1481-6.

  5. Initiation of highly active antiretroviral therapy in advanced AIDS with CD4 < 50 cells/mm3 in a resource-limited setting: efficacy and tolerability. Sungkanuparph S, Kiertiburanakul S, Manosuthi W, Kiatatchasai W, Vibhagool A. Int J STD AIDS. 2005 Mar;16(3):243-6.

  6. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis. Sungkanuparph S, Overton ET, Seyfried W, Groger RK, Fraser VJ, Powderly WG. Clin Infect Dis. 2005 Nov 1;41(9):1326-32. Epub 2005 Sep 29.

  7. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study. Manosuthi W, Chumpathat N, Chaovavanich A, Sungkanuparph S. BMC Infect Dis. 2005 Aug 24;5:67.

  8. Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Overton ET, Sungkanuparph S, Powderly WG, Seyfried W, Groger RK, Aberg JA. Clin Infect Dis. 2005 Oct 1;41(7):1045-8. Epub 2005 Aug 22.

2004

  1. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. Chetchotisakd P, Sungkanuparph S, Thinkhamrop B, Mootsikapun P, Boonyaprawit P. HIV Med. 2004 May;5(3):140-3.

  2. Aspergillosis of the central nervous system: a catastrophic opportunistic infection. Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, Witoonpanich R, Sungkanuparph S, Vibhagool A. Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):119-25.

  3. Case report: Brucellosis: a re-emerging disease in Thailand. Manosuthi W, Thummakul T, Vibhagool A, Vorachit M, Malathum K. Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):109-12.

  4. Clinical experience with high success rate of antiretroviral therapy in elderly HIV-infected patients. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A. Age Ageing. 2004 Sep;33(5):520-1.

  5. Concurrent chromomycosis and aspergillosis of the maxillary sinus. Manosuthi W, Sungkanuparph S, Hongmanee P, Sornmayura P, Laothamatah J, Praneetvatakul V. J Med Assoc Thai. 2004 Sep;87(9):1112-5.

  6. Cryptococcuria as a manifestation of disseminated cryptococcosis and isolated urinary tract infection. Kiertiburanakul S, Sungkanuparph S, Buabut B, Pracharktam R. Jpn J Infect Dis. 2004 Oct;57(5):203-5.

  7. Efficacy of immunotherapy using antigens of Pythium insidiosum in the treatment of vascular pythiosis in humans. Wanachiwanawin W, Mendoza L, Visuthisakchai S, Mutsikapan P, Sathapatayavongs B, Chaiprasert A, Suwanagool P, Manuskiatti W, Ruangsetakit C, Ajello L. Vaccine. 2004 Sep 9;22(27-28):3613-21.

  8. Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infection. Manosuthi W, Sungkanuparph S, Vibhagool A, Rattanasiri S, Thakkinstian A. HIV Med. 2004 Mar;5(2):105-9.

  9. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. Sungkanuparph S, Vibhagool A, Manosuthi W, Kiertiburanakul S, Atamasirikul K, Aumkhyan A, Thakkinstian A. J Med Assoc Thai. 2004 Nov;87(11):1349-54.

  10. Strongyloidiasis in patients at a comprehensive cancer center in the United States. Safdar A, Malathum K, Rodriguez SJ, Husni R, Rolston KV. Cancer. 2004 Apr 1;100(7):1531-6.

  11. Sweet's syndrome: a reaction to non-tuberculous mycobacterial infections. Tuchinda C, Puavilai S, Sathapatayavongs B, Sungkanuparph S, Vibhagool A, Jirasutus S, Rajatanavin N, Timpatanapong P. J Med Assoc Thai. 2004 May;87(5):567-72. Review.

2003

  1. Chronic diarrhoea caused by Cryptococcus neoformans in a non-human immunodeficiency virus-infected patient. Sungkanuparph S, Tanphaichitra D, Pracharktam R. Scand J Infect Dis. 2003;35(3):211-2.

  2. Clinical presentation and medical complication in 59 cases of laboratory-confirmed leptospirosis in Bangkok. Ariyapruchya B, Sungkanuparph S, Dumrongkitchaiporn S. Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):159-64.

  3. Concomitant tuberculous and cryptococcal thyroid abscess in a human immunodeficiency virus-infected patient. Kiertiburanakul S, Sungkanuparph S, Malathum K, Pracharktam R. Scand J Infect Dis. 2003;35(1):68-70.

  4. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Vibhagool A, Sungkanuparph S, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Ingsathit A. Clin Infect Dis. 2003 May 15;36(10):1329-31.

  5. Efavirenz-based regimen as treatment of advanced AIDS with cryptococcal meningitis. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C, Chantratita W. J Acquir Immune Defic Syndr. 2003 May 1;33(1):118-9.

  6. Infections with rapidly growing mycobacteria: report of 20 cases. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Int J Infect Dis. 2003 Sep;7(3):198-205.

  7. Opportunistic infections after the initiation of highly active antiretroviral therapy in advanced AIDS patients in an area with a high prevalence of tuberculosis. Sungkanuparph S, Vibhagool A, Mootsikapun P, Chetchotisakd P, Tansuphaswaswadikul S, Bowonwatanuwong C. AIDS. 2003 Sep 26;17(14):2129-31.

  8. Pneumocystis carinii pneumonia in patients without HIV infection. Saksasithon S, Sungkanuparph S, Thanakitcharu S. J Med Assoc Thai. 2003 Jul;86(7):612-6.

  9. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. J Med Assoc Thai. 2003 Aug;86(8):772-80.

  10. Restriction of vancomycin use at a university hospital in Thailand. Ayuthya SK, Malathum K, Matangkasombut OP. Am J Health Syst Pharm. 2003 May 15;60(10):1053-4.

  11. Utilization of restricted antibiotics in a university hospital in Thailand. Ayuthya SK, Matangkasombut OP, Sirinavin S, Malathum K, Sathapatayavongs B. Southeast Asian J Trop Med Public Health. 2003 Mar;34(1):179-86.

2002

  1. Burkholderia pseudomallei: abscess in an unusual site. Kiertiburanakul S, Sungkanuparph S, Kositchiwat S, Vorachit M. J Postgrad Med. 2002 Apr-Jun;48(2):124-6.

  2. Correlation between susceptibility of Mycobacterium tuberculosis by microtiter plate alamar blue assay and clinical outcomes. Sungkanuparph S, Pracharktam R, Thakkinstian A, Buabut B, Kiatatchasai W. J Med Assoc Thai. 2002 Jul;85(7):820-4.

  3. Spontaneous cryptococcal peritonitis in cirrhotic patients. Sungkanuparph S, Vibhagool A, Pracharktam R. J Postgrad Med. 2002 Jul-Sep;48(3):201-2.

  4. Detection of JC virus infection in progressive multifocal leukoencephalopathy: the first documented case in Thailand. Dujneungkunakorn T, Sungkanuparph S, Vibhagool A, Pairoj W, Chantratita W, Srichunrusami C, Laothamatas J, Pulkes T. J Med Assoc Thai. 2002 Oct;85(10):1139-44.

  5. Eubacterium bacteremia and colon cancer. Sungkanuparph S, Chansirikarnjana S, Vorachit M. Scand J Infect Dis. 2002;34(12):941-3.

2001

  1. Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases. Sungkanuparph S, Sathapatayavongs B, Kunachak S, Luxameechanporn T, Cheewaruangroj W. J Med Assoc Thai. 2001 Apr;84(4):593-601.

  2. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. Singh KV, Malathum K, Murray BE. Antimicrob Agents Chemother. 2001 Dec;45(12):3640-3.

  3. In vitro activity of 19 antimicrobial agents against enterococci from healthy subjects and hospitalized patients and use of an ace gene probe from Enterococcus faecalis for species identification. Duh RW, Singh KV, Malathum K, Murray BE. Microb Drug Resist. 2001 Spring;7(1):39-46.

  4. Disruption of an Enterococcus faecium species-specific gene, a homologue of acquired macrolide resistance genes of staphylococci, is associated with an increase in macrolide susceptibility. Singh KV, Malathum K, Murray BE. Antimicrob Agents Chemother. 2001 Jan;45(1):263-6.

  5. Tuberculous meningitis associated with urinary tract tuberculosis. Chotmongkol V, Kiertiburanakul S. Southeast Asian J Trop Med Public Health. 2001 Jun;32(2):394-6.

2000

  1. Mycetoma and phaeohyphomycosis caused by Phialophora parasitica in Thailand. Pracharktam R, Chongtrakool P, Sriurairatana S, Sathapatayavongs B. J Med Assoc Thai. 2000 Mar;83 Suppl 1:S42-5.

  2. Preliminary report for the application of nucleic acid sequence-based amplification in detection of human cytomegalovirus (HCMV) late pp67 mRNA for diagnosis of HCMV infection. Pairoj W, Srichunrusami C, Chantratita W, Bodhiphala P, Sungkanuparph S, Vibhagool A. J Med Assoc Thai. 2000 Mar;83 Suppl 1:S28-34.